Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Medtronic
Express Scripts
Colorcon
Merck

Last Updated: February 20, 2020

DrugPatentWatch Database Preview

Litigation Details for PIECZENIK v. IDEXX REFERENCE LABORATORIES, INC. (D.N.J. 2010)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

PIECZENIK v. IDEXX REFERENCE LABORATORIES, INC. (D.N.J. 2010)

Docket   Start Trial Date Filed 2010-05-07
Court District Court, D. New Jersey Date Terminated 2010-06-25
Cause 28:1338 Patent Infringement Assigned To Joel A. Pisano
Jury Demand Plaintiff Referred To Tonianne J. Bongiovanni
Parties ABBOTT LABORATORIES; ABBOTT LABORATORIES, INC.; ALLERGAN USA, INC.; AMGEN INC.; AMGEN USA, INC.; BAXTER DIAGNOSTICS INC.; BIOGEN IDEC INC.; BIOGEN IDEC U.S. CORPORATION; CENTOCOR ORTHO BIOTECH PRODUCTS, L.P.; CENTOCOR ORTHO BIOTECH SERVICES; CENTOCOR ORTHO BIOTECH, INC.; CORNING INCORPORATED; DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC.; DR. GEORGE PIECZENIK; DYAX CORPORATION; FOREST LABORATORIES, INC.; GE HEALTHCARE BIO-SCIENCES CORP.; GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP; GE HEALTHCARE INC.; GE HEALTHCARE STRATEGIC SOURCING CORPORATION; GENZYME CORPORATION; GILEAD SCIENCES, INC.; HOWARD HUGHES MEDICAL INSTITUTE; IDEXX REFERENCE LABORATORIES, INC.; INTERNATIONAL BUSINESS MACHINES CORP.; INVITROGEN CORPORATION; JOHN DOES 1 THROUGH 61; JOHNSON & JOHNSON; MILLENIUM PHARMACEUTICALS, INC.; ONYX PHARMACEUTICALS, INC.; ORTHO-MCNEIL JANSSEN PHARMACEUTICALS, INC.; ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC; ORTHO-MCNEIL PHARMACEUTICAL, INC.; ORTHO-MCNEIL, INC.; OSI PHARMACEUTICALS, INC.; PERKINELMER HEALTH SCIENCES, INC.; SCHERING BERLIN INC.; SCHERING CORPORATION; SCHERING-PLOUGH BIOPHARMA; SCHERING-PLOUGH INTERNATIONAL, INC.; SCHERING-PLOUGH PRODUCTS, INC.; THE DOW AGROSCIENCES LLC; THE DOW CHEMICAL COMPANY (DELAWARE); THE DOW CORNING CORPORATION; WYETH HOLDINGS CORPORATION; WYETH PHARMACEUTICALS INC.; ZYMOGENETICS, INC.; ZYMOGENETICS, LLC
Patents 5,403,484; 5,571,698
Attorneys ARNOLD B. CALMANN; CYNTHIA STENCEL BETZ; DAVID LEIT; DAVID W. FIELD; DONALD A. ROBINSON; ELIOR DANIEL SHILOH; ETHAN JOHN STEWARD; GEORGE C. JONES; GEORGE PIECZENIK; GERI L. ALBIN; GURBIR S. GREWAL; JEFFREY S. SOOS; JONATHAN M.H. SHORT; KEITH J. MILLER; LIZA M. WALSH; MATTHEW RICHARD SAVARE; MICHAEL E. PATUNAS; MICHAEL R. GRIFFINGER; ROBERT J. SCHOENBERG; ROBERT L. BAECHTOLD; ROBERT M. GOODMAN; RONALD A. GILLER; RUKHSANAH L. SINGH; SHEILA F. MCSHANE; STEPHANIE R. WOLFE; STEPHEN R. BUCKINGHAM; SYMONE J. REDWINE; THOMAS R. CURTIN; WILLIAM J. HELLER
Firms Connell, Foley; Fidelity National Law Group; Fitzpatrick, Cella, Harper & Scinto, Esqs.; George C. Jones; George Pieczenik; Gordon & Rees, LLP; Greenbaum, Rowe, Smith & Davis, LLP; Howrey LLP; Lowenstein Sandler; Lowenstein Sandler PC; McCarter & English, LLP; McCarter and English, LLP; Patunas Tarantino LLC; Riker, Danzig, Scherer, Hyland & Perretti, LLP; Stephanie R. Wolfe; Thomas R Curtin
Link to Docket External link to docket
Biologic Drugs cited in PIECZENIK v. IDEXX REFERENCE LABORATORIES, INC.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for PIECZENIK v. IDEXX REFERENCE LABORATORIES, INC. (D.N.J. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-06-01 24 Corp. under U.S. Patent Nos. 5,223,409, 5,403,484 andfor 5,571,698 and associated patent rights. For license…Pieczenik 363 patent is a “pioneering patent” and the Ladner/Dyax patents are “improvement patents”. 9. There…Pieczenik’s ‘363 patent is a pioneering patent in the area of combinatorial chcmistry. The patent was filed …step was to classify the patent as a pioneering patent or an improvement patent iii relation to the prior…363 as well as the patent claims “as a whole”. The ‘363 patent is the pioneering patent, the Ladner ‘409,484 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKinsey
Moodys
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.